Rothschild Investment »

Inhibrx Biosciences shares owned by Rothschild Investment

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2024-06-30 $42 3 14.33

More positions owned by Rothschild Investment

Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Jpmorgan Chase & Co Stock (JPM)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Blackstone Stock (BX)
Costco Whsl Corp Stock (COST)
Invesco Ftse Rafi Us 1000 Etf Etf (PRF)
Amazon Stock (AMZN)
Chevron Corp Stock (CVX)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Abbvie Stock (ABBV)
Amgen Stock (AMGN)
Palo Alto Networks Stock (PANW)

View all positions for Rothschild Investment

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences